Abnormal Lipid Signaling Characterizes Diastolic Dysfunction in Pediatric Cardiomyopathy

Area of Science:

• Cardiology
• Metabolomics
• Molecular Biology

Background:

• Pediatric cardiomyopathy is a significant cause of diastolic heart failure.
• The underlying molecular mechanisms of this condition, particularly diastolic dysfunction, are not well understood.
• Identifying specific molecular signatures is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the molecular mechanisms of diastolic dysfunction in pediatric cardiomyopathy.
• To identify a distinct metabolic and transcriptomic signature associated with diastolic dysfunction.
• To explore potential therapeutic targets for childhood cardiomyopathy.

Main Methods:

• Global myocardial transcriptomic and blood lipidomic profiling were performed.
• A machine learning model was developed using identified gene markers to classify diastolic dysfunction.
• Induced pluripotent stem cell-derived cardiomyocytes from patients were analyzed for lipid accumulation and mitochondrial function.
• The efficacy of semaglutide in rescuing cellular dysfunction was assessed.

Main Results:

• A unique metabolic signature characterized by dysregulated lipid signaling was identified in diastolic dysfunction.
• Excess saturated lipids and impaired lipid oxidation correlated with myocardial gene expression changes.
• The machine learning model accurately classified diastolic dysfunction across different cardiomyopathy subtypes.
• Patient-derived cardiomyocytes showed lipid accumulation and mitochondrial dysfunction, which were ameliorated by semaglutide treatment.

Conclusions:

• Diastolic dysfunction in pediatric cardiomyopathy is associated with a distinct molecular phenotype involving abnormal lipid signaling.
• Impaired lipid metabolism and mitochondrial dysfunction are key features of this condition.
• Targeting abnormal lipid signaling, potentially with agents like semaglutide, represents a promising therapeutic strategy for childhood cardiomyopathy.